Kay MA - Search Results

1

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.

Lisowski L, Dane AP, Chu K, Zhang Y, Cunningham SC, Wilson EM, Nygaard S, Grompe M, Alexander IE, Kay MA. Lisowski L, et al. Among authors: kay ma. Nature. 2014 Feb 20;506(7488):382-6. doi: 10.1038/nature12875. Epub 2013 Dec 25. Nature. 2014. PMID: 24390344 Free PMC article.

2

Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Overturf K, al-Dhalimy M, Ou CN, Finegold M, Tanguay R, Lieber A, Kay M, Grompe M. Overturf K, et al. Hum Gene Ther. 1997 Mar 20;8(5):513-21. doi: 10.1089/hum.1997.8.5-513. Hum Gene Ther. 1997. PMID: 9095403

3

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.

Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA. Snyder RO, et al. Among authors: kay ma. Nat Genet. 1997 Jul;16(3):270-6. doi: 10.1038/ng0797-270. Nat Genet. 1997. PMID: 9207793

4

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.

Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Snyder RO, et al. Among authors: kay ma. Nat Med. 1999 Jan;5(1):64-70. doi: 10.1038/4751. Nat Med. 1999. PMID: 9883841

5

Efficient lentiviral transduction of liver requires cell cycling in vivo.

Park F, Ohashi K, Chiu W, Naldini L, Kay MA. Park F, et al. Among authors: kay ma. Nat Genet. 2000 Jan;24(1):49-52. doi: 10.1038/71673. Nat Genet. 2000. PMID: 10615126

6

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, Glader B, Chew AJ, Tai SJ, Herzog RW, Arruda V, Johnson F, Scallan C, Skarsgard E, Flake AW, High KA. Kay MA, et al. Nat Genet. 2000 Mar;24(3):257-61. doi: 10.1038/73464. Nat Genet. 2000. PMID: 10700178 Clinical Trial.

7

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

Ohashi K, Marion PL, Nakai H, Meuse L, Cullen JM, Bordier BB, Schwall R, Greenberg HB, Glenn JS, Kay MA. Ohashi K, et al. Among authors: kay ma. Nat Med. 2000 Mar;6(3):327-31. doi: 10.1038/73187. Nat Med. 2000. PMID: 10700236

8

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors.

Nakai H, Storm TA, Kay MA. Nakai H, et al. Among authors: kay ma. Nat Biotechnol. 2000 May;18(5):527-32. doi: 10.1038/75390. Nat Biotechnol. 2000. PMID: 10802620

9

Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA. Yant SR, et al. Among authors: kay ma. Nat Genet. 2000 May;25(1):35-41. doi: 10.1038/75568. Nat Genet. 2000. PMID: 10802653

10

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.

Kay MA, Glorioso JC, Naldini L. Kay MA, et al. Nat Med. 2001 Jan;7(1):33-40. doi: 10.1038/83324. Nat Med. 2001. PMID: 11135613 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters